中文    |     English    |    Subscribe    |    Free trial    |     Login
Linkedbio is the newly launched services provided by Lingmed. We help companies to understand and monitor China market opportunities, define the right strategies and work with the right partners
In-lisence
Lingmed analyst team will support you on in-licensing assets. We support your asset screening - the search will be tailed based on your search criteria to provide China market monitoring, including asset screening...
Out -lisence
Lingmed analyst team supports your out-license activities to enter China or EU market as your extended BD arm, we will analyze your asset and provide summary and highlights of your asset in local language and push out to Lingmed marketing channel to generate ...
Lingmed analyst team conducts desk researches and interviews to get insights on China market, we provide tailored product China market sizing analysis, deal valuation and competitive landscape reports to our clients.
Be more effecient in your decision making process about BD activities in China. Deep dive into China market to define the right products for the market and define the right strategies for China. Stay informed and monitoring the innovative landscape
  • Screening the market for BD opportunities quarterly
  • Understand the implication of a new policy
  • Understand the market trend and unspoken rules
Linkedbio China healthcare market reports
  • Weekly China healthcare market news
  • Access to achieved reports
  • Free search and download historical achieved reports
  • During the subscription, one time complimentary initial connection on partnering support
Lingmed is the exclusive partner for Evaluate, Biotechgate and SOURCE CHINA in China